China's Comprehensive Health Care Reform Plan: Implications for Pharmaceutical and Device Firms

Global Life Sciences: China Update

On April 6, the State Council of China made public the Guideline on Further Reforming the Health Care System, and on the following day the Action Plan for Health Care System Reform: 2009 - 2011. This signals the first step in China’s long-anticipated health care reform, which will reshape its ailing health care system and bring new opportunities and challenges to pharmaceutical, biologics and medical device companies doing business in China. While specific measures for the health care reform remain to be determined, companies may have to adjust market access, promotion and marketing strategies in China.